Connect MM- The Multiple Myeloma Disease Registry
Latest Information Update: 18 Jul 2024
At a glance
- Drugs Lenalidomide (Primary) ; Bortezomib; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- Sponsors Celgene Corporation
- 08 Jul 2024 Planned number of patients changed from 3000 to 3311.
- 08 Jul 2024 Status changed from active, no longer recruiting to recruiting.
- 12 Dec 2023 Planned End Date changed from 31 Dec 2024 to 15 Aug 2031.